February 2, 2022
February 2-4, 2022. [EVENTS] Company ; METAglut1™ We are thrilled to share our experience at the 31st Congress of the Société Française de Neurologie Pédiatrique (SFNP), […]
September 16, 2021
September 16, 2021. [NEWS] Company Lisses et Paris, 16 septembre 2021. Sebia, leader mondial du diagnostic in vitro (DIV) dans le domaine du myélome multiple et des […]
June 19, 2021
June 19, 2021. [NEWS] Company ; METAglut1™ We were thrilled to attend the 3rd European Conference on GLUT1 Deficiency, which took place virtually, and during which […]
June 11, 2021
June 11, 2021. [EVENTS] Company ; METAglut1™ We were thrilled to eventually attend the 3rd European Conference on GLUT1 Deficiency, which took place virtually. After eagerly […]
March 22, 2021
March 22, 2021. [NEWS] Company We are proud to announce that we have obtained our Quality Management System Certification based on the international standard NF EN […]
January 15, 2020
January 15-17, 2020. [EVENTS] Company ; METAglut1™ We are thrilled that our intermediate results of our validation study for METAglut1™ were shared for the first time at […]
December 16, 2019
December 16, 2019. [SCIENTIFIC PUBLICATION] Company We are pleased to highlight our collaborative research published in Therapie, titled “Early patient access to health technologies: Is innovation […]
July 11, 2019
July 11-12, 2019. [EVENTS] Company ; METAglut1™ We are thrilled to participate in the 2019 annual conference of the American Association GLUT1 Deficiency Foundation, happening in […]
June 21, 2019
June 21, 2019. [AWARDS] Company Alongside our partners INRIA and Université Paris-Saclay, we are proud to announce that we laureate of the inaugural PhD Paris Region […]
